Statement Of Cash Flows [Abstract]

GENFLOW BIOSCIENCES PLC - Filing #5893549

Concept 2024-01-01 to
2024-12-31
As at
2024-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2022-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operating activities
1,082,273 GBP
1,660,875 GBP
Cash flows from (used in) investing activities [abstract]
Purchase of property, plant and equipment, classified as investing activities
- GBP
2,439 GBP
Cash flows from (used in) investing activities
- GBP
2,439 GBP
Cash flows from (used in) financing activities [abstract]
Cash flows from (used in) financing activities
656,635 GBP
- GBP
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes
425,638 GBP
1,663,314 GBP
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
20,346 GBP
8,937 GBP
Cash and cash equivalents
278,682 GBP
683,974 GBP
2,356,225 GBP

Talk to a Data Expert

Have a question? We'll get back to you promptly.